LRRK2 and Parkinson disease: Collectively, these findings pinpoint LRRK2 as a central regulator of ferroptosis and neuroinflammation in Parkinson’s disease, offering compelling evidence for its therapeutic potential and underscoring its broader significance in neurodegenerative pathophysiology.However, it is important to acknowledge the limitations of the current study.